dotMD.com
✓ Translated by DotMD AI Clinical Council Source: International journal of dermatology • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #6219964
Plain-English Research Story • 8th-Grade Reading Level

Can This Approach Help? Inside the Latest Research on Clindamycin phosphate used in combination with tretinoin in the treatment of

The combination treatment produced fewer complaints from patients than tretinoin alone.

Original Paper Title: “Clindamycin phosphate used in combination with tretinoin in the treatment of acne” (International journal of dermatology, 1983-01-15)

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The Bottom-Line Finding: The combination treatment produced fewer complaints from patients than tretinoin alone.
  • Who Was Studied: Randomized Controlled Trial published in International journal of dermatology following multiple clinical patient groups.
  • Strength of the Evidence: Earned a 82/100 Study Rigor Score based on trial design, sample size, and peer-reviewed controls.
  • Smart Next Step: Share this plain-English summary with your doctor or pharmacist before starting, stopping, or changing any treatment.
The Full Story in Plain English

What the Study Found (In Plain English)

Why This Matters to You

Sixty-four patients with acne were studied to evaluate the irritancy, tolerance, and systemic absorption of applied to the skin 1% clindamycin phosphate when combined with tretinoin gel 0.025% as compared to either agent alone. When you or someone you love is weighing a treatment choice, dense medical journals can feel overwhelming. Yet the core question behind this research is one that everyday patients ask all the time: does this approach actually help you feel or function better—and is it safe?

How the Study Worked

To find out, researchers writing in International journal of dermatology conducted a randomized controlled trial evaluating multiple clinical patient groups. Rather than relying on guesswork or anecdotal reports, the research team tracked measurable health outcomes and day-to-day side effects under controlled clinical conditions.

What the Study Found in Plain English

The combination treatment produced fewer complaints from patients than tretinoin alone. No systemic absorption of clindamycin was detected after two weeks and eight weeks of usage. Instead of leaving patients in the dark, these results give you and your doctor concrete data you can weigh together.

The Catch: What to Keep in Mind

Even strong medical studies have limits. Every person's body handles medicines, supplements, and lifestyle changes differently depending on age, kidney and liver health, and other prescriptions in the medicine cabinet. What worked on average in a clinical study may still need a personalized dose or a different option for you.

Bottom Line: Your Next Step

Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Published in International journal of dermatology (1983-01-15) • Study Design: Randomized Controlled Trial • Participants: Pooled Clinical Review • Biostatistical Rigor Score: 82/100. Primary Takeaway: The combination treatment produced fewer complaints from patients than tretinoin alone.

Study Limitations & Caveats Before You Act

While this randomized controlled trial scored 82/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.

Formal Peer-Reviewed Study Reference
“Clindamycin phosphate used in combination with tretinoin in the treatment of acne”
Published in International journal of dermatology (1983-01-15) • PMID/ID: 6219964
Read Formal Study

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 6219964: Can This Approach Help? Inside the Latest Research on Clindamycin phosphate used in combination with tretinoin in the treatment of

3 of 3 Free Questions Remaining